<\/b><\/p>\n
<\/b><\/p>\n
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.<\/p>\n
Recent Increase Seen in COVID-19 Incidence Among 18- to 22-Year-Olds<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — During Aug. 2 to Sept. 5, 2020, there was a 55.1 percent increase in the weekly incidence of COVID-19 nationally among young adults aged 18 to 22 years, according to research published in the Sept. 29 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n COVID-19-Related Hospital Death Up With Psychiatric Diagnosis<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Patients with any prior psychiatric diagnosis have an increased risk for COVID-19-related hospital death, according to a research letter published online Sept. 30 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Cancer Mortality Higher for U.S. Counties With Persistent Poverty<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — U.S. counties with persistent poverty (\u226520 percent of residents in poverty since 1980) have higher rates of cancer mortality, according to a study published online Sept. 30 in Cancer Epidemiology, Biomarkers & Prevention<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n No Race Difference Found in COVID-19 Mortality Rates at Same Medical Center<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic Black and Hispanic patients versus non-Hispanic White patients, according to a study published online Sept. 25 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Current Trends in COVID-19 Reported for U.S. Youth<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — The incidence of COVID-19 was higher in adolescents than among children during May to September 2020, according to research published in the Sept. 28 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Hospital Admissions Not Related to COVID-19 Fell in Early 2020<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Global Death Toll From COVID-19 Passes 1 Million<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The global COVID-19 pandemic reached a grim new milestone on Tuesday: 1 million dead.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Johns Hopkins University<\/a><\/p>\n U.S. Government to Ship Millions of Rapid COVID-19 Tests This Week<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The U.S. government will start distributing millions of rapid COVID-19 tests to states this week with the goal of reopening schools.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Generalized Epilepsy Tied to Higher Sleep Apnea Risk<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — Patients with generalized epilepsy have a higher risk for obstructive sleep apnea (OSA), according to a study published in the October issue of Epilepsy & Behavior<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Women With AMI-Cardiogenic Shock Treated Less Aggressively<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — Among young adults with acute myocardial infarction-cardiogenic shock (AMI-CS), women are treated less aggressively and have higher in-hospital mortality than men, according to a study published online Sept. 29 in Circulation: Heart Failure<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Outcomes of In-Hospital Cardiac Arrest Poor in COVID-19 Patients<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — None of 54 patients hospitalized with COVID-19 with in-hospital cardiac arrest who underwent cardiopulmonary resuscitation (CPR) survived to discharge, according to a research letter published online Sept. 28 in JAMA Internal Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial (subscription or payment may be required)<\/a><\/p>\n Private Health Plans Pay Hospitals 247 Percent of Medicare<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.<\/p>\n More Information<\/a><\/p>\n Infants of COVID-19-Infected Mothers Doing Well in Short Term<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Infants born to mothers testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not have a higher frequency of adverse outcomes than those born to mothers testing negative, according to a brief report published online Sept. 18 in Clinical Infectious Diseases<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Clinical Severity Lower With Vitamin D Sufficiency in COVID-19<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Vitamin D sufficiency is associated with reduced clinical severity, inpatient mortality, and serum levels of C-reactive protein (CRP) among patients infected with COVID-19, according to a study published online Sept. 25 in PLOS ONE<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n <10 Percent of U.S. Population Has Antibodies to SARS-CoV-2<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Fewer than 10 percent of the U.S. adult population formed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the pandemic, according to a study published online Sept. 25 in The Lancet<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Non-English speakers are less likely to have completed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and have a higher proportion of positive tests compared with English speakers, according to a research letter published online Sept. 24 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — About one-fifth of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic and their viral load is comparable to that of patients with mild symptoms, according to a study published online Sept. 22 in Thorax<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Median Age of COVID-19 Cases Declined in May to August in U.S.<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — From May to August 2020, there was a decrease in the median age of COVID-19 cases in the United States, according to research published in the Sept. 23 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n HRRP Tied to Decrease in 30-Day Readmission Rates for COPD<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — For patients with chronic obstructive pulmonary disease (COPD), implementation of the Hospital Readmissions Reduction Program (HRRP) is associated with a reduction in 30-day readmissions but may increase mortality, according to a study published online Sept. 1 in the American Journal of Respiratory and Critical Care Medicine<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Acute Kidney Injury Ups Risk for Death in COVID-19 Patients<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with a significantly higher risk for in-hospital death, according to a study published online Sept. 19 in the American Journal of Kidney Diseases<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Flu shots may be more important than ever this year, as COVID-19 presents new challenges for clinicians and communities this flu season. HD Live! spoke with Nadia Eltaki, M.D., director of clinical operations at Sibley Memorial Hospital in Washington, D.C., to discuss how clinicians can potentially lessen the potential for an overlapping superinfection, or “twindemic.”<\/p>\n More Information<\/a><\/p>\n U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The U.S. COVID-19 death toll reached the tragic milestone of 200,000 on Tuesday, with at least 22 states now reporting a rise in new cases. Just last Monday, only nine states were reporting increases in new COVID-19 cases, CNN<\/i> reported. For the most part, the case spikes are showing up in the country’s heartland and the Midwest.<\/p>\n CNN<\/i> Article<\/a><\/p>\n Stricter Vaccine Approval Rules Coming From FDA<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Stricter guidelines for emergency use authorization of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The final stage of clinical trials for Johnson & Johnson’s COVID-19 vaccine have started, the company announced Tuesday.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n Red Blood Cell Distribution Width, Mortality Tied in COVID-19<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For patients with COVID-19, elevated red blood cell distribution width (RDW) is associated with increased mortality risk, according to a study published online Sept. 23 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Most People With SARS-CoV-2 Do Not Remain Asymptomatic<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is lower among contacts of people with asymptomatic infection, according to a review published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n AKI Occurs in 7 Percent of Those Hospitalized With COVID-19<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Acute kidney injury (AKI) occurs in 7 percent of patients hospitalized with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 22 in the Clinical Journal of the American Society of Nephrology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Rates of COVID-19 Infection Higher in Blacks, Hispanics<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Black and Hispanic individuals are experiencing an excess burden of severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Perrigo Asthma Inhalers Recalled Due to Clog Risk<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.<\/p>\n More Information<\/a><\/p>\n Many School Employees at Increased Risk for Severe COVID-19<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — Nearly half of all school employees meet the U.S. Centers for Disease Control and Prevention definition for increased or potentially increased risk for severe COVID-19, according to a study published online Sept. 17 in Health Affairs<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n COVID-19 Death Toll Nears 200,000 in the United States<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — As the U.S. COVID-19 case count neared 200,000 on Monday, public health experts debated whether the spread of the virus will continue to slow or a new surge will come, as cold weather returns to much of the country.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n CDC Removes New COVID-19 Guidelines Just Days After Posting Them<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — New U.S. Centers for Disease Control and Prevention website guidelines suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet and that indoor ventilation is crucial to prevent its spread were removed from the agency’s website late Monday morning.<\/p>\n The Washington Post<\/i> Article<\/a><\/p>\n AstraZeneca Releases COVID-19 Vaccine Trial Plans<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts about a COVID-19 vaccine, and experts are worried that an unproven or unsafe vaccine may be released prematurely due to pressure from President Donald Trump, The New York Times<\/i> reported.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n Individuals With Autism at Risk for Other Health Conditions<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — Individuals with autism have increased health risks even when considering lifestyle factors, according to a study published online Sept. 9 in Autism<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 14 to 18, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n